Loading...
Podoplanin: An emerging cancer biomarker and therapeutic target
Podoplanin (PDPN) is a transmembrane receptor glycoprotein that is upregulated on transformed cells, cancer associated fibroblasts and inflammatory macrophages that contribute to cancer progression. In particular, PDPN increases tumor cell clonal capacity, epithelial mesenchymal transition, migratio...
Saved in:
| Published in: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980289/ https://ncbi.nlm.nih.gov/pubmed/29575529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13580 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|